
OCTAGON CAPITAL ADVISORS LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | GOSS | 17.05M | $44.84M |
![]() | TSHA | 9.07M | $29.65M |
![]() | COGT | 2.87M | $41.27M |
![]() | TRVI | 2.81M | $25.76M |
![]() | NUVB | 2.63M | $9.74M |
![]() | OCUL | 2.62M | $30.67M |
![]() | DNTH | 2.42M | $95.10M |
![]() | MNMD | 2.13M | $25.11M |
![]() | AVBP | 1.97M | $36.37M |
![]() | ABVX | 1.32M | $112.49M |
![]() | KALV | 1.27M | $15.51M |
![]() | DBVT | 1.02M | $10.18M |
![]() | APLS | 904K | $20.45M |
![]() | CNTA | 830K | $20.13M |
![]() | PHVS | 723K | $18.03M |
![]() | PEPG | 700K | $3.23M |
![]() | KYMR | 360K | $20.38M |
![]() | MRUS | 308K | $29.00M |
![]() | NGNE | 252K | $4.37M |
![]() | MAZE | 178K | $4.61M |

Gossamer Bio, Inc.
GOSS
Shares Held
17.05M
Value
$44.84M

Taysha Gene Therapies, Inc.
TSHA
Shares Held
9.07M
Value
$29.65M

Cogent Biosciences, Inc.
COGT
Shares Held
2.87M
Value
$41.27M

Trevi Therapeutics, Inc.
TRVI
Shares Held
2.81M
Value
$25.76M

Nuvation Bio Inc.
NUVB
Shares Held
2.63M
Value
$9.74M

Ocular Therapeutix, Inc.
OCUL
Shares Held
2.62M
Value
$30.67M

Dianthus Therapeutics, Inc.
DNTH
Shares Held
2.42M
Value
$95.10M

Mind Medicine (MindMed) Inc.
MNMD
Shares Held
2.13M
Value
$25.11M

ArriVent BioPharma, Inc. Common Stock
AVBP
Shares Held
1.97M
Value
$36.37M

Abivax S.A.
ABVX
Shares Held
1.32M
Value
$112.49M

KalVista Pharmaceuticals, Inc.
KALV
Shares Held
1.27M
Value
$15.51M

DBV Technologies S.A.
DBVT
Shares Held
1.02M
Value
$10.18M

Apellis Pharmaceuticals, Inc.
APLS
Shares Held
904K
Value
$20.45M

Centessa Pharmaceuticals plc
CNTA
Shares Held
830K
Value
$20.13M

Pharvaris N.V.
PHVS
Shares Held
723K
Value
$18.03M

PepGen Inc.
PEPG
Shares Held
700K
Value
$3.23M

Kymera Therapeutics, Inc.
KYMR
Shares Held
360K
Value
$20.38M

Merus N.V.
MRUS
Shares Held
308K
Value
$29.00M

Neurogene Inc.
NGNE
Shares Held
252K
Value
$4.37M

Maze Therapeutics, Inc.
MAZE
Shares Held
178K
Value
$4.61M
